Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viens

Showing results (111-120 of 244) with videos related to

Pageof 25
Sort By:
Hematology and Cell Therapy|May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technologyC Chabannon, G Novakovitch, J L Blache, et al.
Surgery, Gynecology & Obstetrics|September 1, 1993
Results of a prospective study with comparison of clinical, endosonographic, computed tomography, magnetic resonance imaging and pathologic staging of advanced gynecologic carcinoma and recurrenceG Houvenaeghel, J R Delpero, R Rosello, et al.
European Cytokine Network|June 12, 2001
Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trialG Gravis, M Mousseau, J Y Douillard, et al.
Bulletin Du Cancer|November 1, 1993
[Simultaneous radiotherapy and chemotherapy in the treatment of advanced cancer of the cervix uteri]M Resbeut, M Noirclerc, P Viens, et al.
Current Medical Research and Opinion|March 11, 2010
Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancerB Kaufman, Y Wu, M M Amonkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le CancerS Négrier, A Caty, T Lesimple, et al.
British Journal of Cancer|June 10, 2011
A seven-gene prognostic model for platinum-treated ovarian carcinomasR Sabatier, P Finetti, J Bonensea, et al.
Pathologie-Biologie|May 1, 1988
[Randomized trial of empirical antibiotic therapy in febrile episodes after bone marrow transplantation. Comparison of an aminoglycoside-beta lactam (tobramycin-ticarcillin) combination with 2 beta-lactam antibiotics (ticarcillin-latamoxef)]P Viens, D Maraninchi, M H Gaspard, et al.
Bone Marrow Transplantation|December 12, 2002
Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II studyF Viret, F Bertucci, D Genre, et al.
British Journal of Cancer|May 1, 1994
p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP resultsJ Jacquemier, J P Molès, F Penault-Llorca, et al.
Pageof 25

Showing results (111-120 of 244) with videos related to

Sort By:
Pageof 25
Hematology and Cell Therapy|May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technologyC Chabannon, G Novakovitch, J L Blache, et al.
Surgery, Gynecology & Obstetrics|September 1, 1993
Results of a prospective study with comparison of clinical, endosonographic, computed tomography, magnetic resonance imaging and pathologic staging of advanced gynecologic carcinoma and recurrenceG Houvenaeghel, J R Delpero, R Rosello, et al.
European Cytokine Network|June 12, 2001
Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trialG Gravis, M Mousseau, J Y Douillard, et al.
Bulletin Du Cancer|November 1, 1993
[Simultaneous radiotherapy and chemotherapy in the treatment of advanced cancer of the cervix uteri]M Resbeut, M Noirclerc, P Viens, et al.
Current Medical Research and Opinion|March 11, 2010
Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancerB Kaufman, Y Wu, M M Amonkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le CancerS Négrier, A Caty, T Lesimple, et al.
British Journal of Cancer|June 10, 2011
A seven-gene prognostic model for platinum-treated ovarian carcinomasR Sabatier, P Finetti, J Bonensea, et al.
Pathologie-Biologie|May 1, 1988
[Randomized trial of empirical antibiotic therapy in febrile episodes after bone marrow transplantation. Comparison of an aminoglycoside-beta lactam (tobramycin-ticarcillin) combination with 2 beta-lactam antibiotics (ticarcillin-latamoxef)]P Viens, D Maraninchi, M H Gaspard, et al.
Bone Marrow Transplantation|December 12, 2002
Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II studyF Viret, F Bertucci, D Genre, et al.
British Journal of Cancer|May 1, 1994
p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP resultsJ Jacquemier, J P Molès, F Penault-Llorca, et al.
Pageof 25